Centessa Pharmaceuticals News

Buy Rating Affirmed for Centessa Pharmaceuticals Amid Promising ORX750 Prospects and Favorable Trial Results

TipRanksApr 12 01:38 ET

Analysts' Top Healthcare Picks: AstraZeneca (AZN), Centessa Pharmaceuticals (CNTA)

TipRanksApr 10 07:11 ET

Centessa Pharmaceuticals Analyst Ratings

BenzingaApr 1 12:24 ET

Analysts Offer Insights on Healthcare Companies: Actinium Pharmaceuticals (ATNM) and Centessa Pharmaceuticals (CNTA)

TipRanksApr 1 10:20 ET

Upgraded Buy Rating and Price Target for Centessa Pharmaceuticals on SerpinPC's Market Potential

TipRanksMar 6 23:17 ET

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Centessa Pharmaceuticals (CNTA) and G1 Therapeutics (GTHX)

TipRanksFeb 13 05:41 ET

Centessa Pharmaceuticals: Buy Rating Backed by Strong Pipeline and Positive Drug Data

TipRanksFeb 12 08:18 ET

Buy Rating Affirmed for Centessa Pharmaceuticals on Strong R&D Prospects and Market Potential

TipRanksFeb 1 00:06 ET

Analysts Offer Insights on Healthcare Companies: Centessa Pharmaceuticals (CNTA) and Vertex Pharmaceuticals (VRTX)

TipRanksDec 4, 2023 07:31 ET

Analysts Offer Insights on Healthcare Companies: Centessa Pharmaceuticals (CNTA), Lantheus (LNTH) and Carisma Therapeutics (CARM)

TipRanksDec 1, 2023 08:40 ET

Jefferies Upgrades Centessa to Buy, Cites Upcoming Data for Narcolepsy Drug

Seeking AlphaNov 15, 2023 14:36 ET

Centessa Pharmaceuticals Analyst Ratings

BenzingaNov 15, 2023 06:19 ET

Centessa Pharmaceuticals' Growth Potential: Diversified Drug Pipeline and Market Opportunities – A Buy Rating Analysis

TipRanksNov 15, 2023 04:15 ET

Morgan Stanley Upgrades Centessa Pharmaceuticals to Equal-Weight, Raises Price Target to $8

BenzingaOct 26, 2023 05:07 ET

Centessa Pharmaceuticals Analyst Ratings

BenzingaOct 26, 2023 05:05 ET

Hold Rating for Centessa Pharmaceuticals: Potential of ORX750 and Considerations for Future Development

TipRanksOct 26, 2023 04:50 ET

Analysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), Centessa Pharmaceuticals (CNTA)

TipRanksSep 25, 2023 07:10 ET

Analysts Conflicted on These Healthcare Names: NeuBase Therapeutics (NBSE) and Centessa Pharmaceuticals (CNTA)

TipRanksAug 16, 2023 07:20 ET

Goldman Sachs Maintains Neutral on Centessa Pharmaceuticals, Raises Price Target to $5

BenzingaAug 15, 2023 08:44 ET

Centessa Pharmaceuticals Analyst Ratings

BenzingaAug 15, 2023 08:43 ET